Evidence map›Paper›PMID 31061469›Full record

ArticleScientific reports2019

Identification of regulatory variants associated with genetic susceptibility to meningococcal disease.

Lisa Borghini, Eileen Png, Alexander Binder, Victoria J Wright, Ellie Pinnock, Ronald de Groot, Jan Hazelzet, Marieke Emonts, Michiel Van der Flier, Luregn J Schlapbach and 14 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Recurrent invasive meningococcal infections - quantifying the risk, Germany, 2002 to 2018.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 20 institutions in 10 countries.

Lisa BorghiniHuman Genetics, Genome Institute of Singapore, Singapore, Singapore. borghini.lisa@gmail.com.
Eileen PngInfectious diseases, Genome Institute of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0001-5586-6395
Alexander BinderDepartment of General Pediatrics, Medical University of Graz, Graz, Austria.
Victoria J WrightSection for Paediatrics, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-7826-1516
Ellie PinnockMicropathology Ltd, University of Warwick, Warwick, UK.
Ronald de GrootDepartment of Pediatrics and Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Jan HazelzetDepartment of Pediatrics, Erasmus Medical Center-Sophia Children's hospital, University Medical Center, Rotterdam, The Netherlands.
Marieke EmontsInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Michiel Van der FlierDepartment of Pediatrics and Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Luregn J SchlapbachFaculty of Medicine, The University of Queensland, Brisbane, Australia.ORCID http://orcid.org/0000-0003-2281-2598
Suzanne AndersonMedical Research Council Unit Gambia, Banjul, The Gambia.
Fatou SeckaMedical Research Council Unit Gambia, Banjul, The Gambia.
Antonio SalasUnidade de Xenética, Departamento de Anatomía Patolóxica e Ciencias Forenses, Instituto de Ciencias Forenses, Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, Instituto de Investigaciones Sanitarias (IDIS), Hospital Clínico Universitario de Santiago, Galicia, Spain.ORCID http://orcid.org/0000-0002-2336-702X
Colin FinkMicropathology Ltd, University of Warwick, Warwick, UK.
Enitan D CarrolInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Andrew J PollardOxford Vaccine Group, Department of Pediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Lachlan J CoinInstitute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, 4072, Australia.
Taco W KuijpersDivision of Pediatric Hematology, Immunology and Infectious diseases, Emma Children's Hospital Academic Medical Center, Amsterdam, The Netherlands.
Federico Martinon-TorresTranslational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-9023-581X
Werner ZenzDepartment of General Pediatrics, Medical University of Graz, Graz, Austria.
Michael LevinSection for Paediatrics, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, UK.
Martin L HibberdInfectious diseases, Genome Institute of Singapore, Singapore, Singapore.
Sonia DavilaHuman Genetics, Genome Institute of Singapore, Singapore, Singapore. sonia.davila@singhealth.com.sg.
EUCLIDS consortium
Imperial College London · GBComplejo Hospitalario Universitario de Santiago · ESMedical University of Graz · ATMRC Unit the Gambia · GMPortsmouth Hospitals NHS Trust · GBRadboud University Nijmegen · NLUniversidade de Santiago de Compostela · ESUniversity of Liverpool · GBAmsterdam UMC Location University of Amsterdam · NLCambridge University Hospitals NHS Foundation Trust · GBHospital Universitario Virgen de la Arrixaca · ESLandeskrankenhaus Feldkirch · ATNottingham University Hospitals NHS Trust · GBUniversity of Bern · CHErasmus MC · NLHospital General Universitario Gregorio Marañón · ESHospital Universitario 12 De Octubre · ESHospital Universitario Central de Asturias · ESPoole Hospital NHS Foundation Trust · GBUniversity Hospital Southampton NHS Foundation Trust · GB

Funding

Department of Health
6 · The paper itself

Abstract

Non-coding genetic variants play an important role in driving susceptibility to complex diseases but their characterization remains challenging. Here, we employed a novel approach to interrogate the genetic risk of such polymorphisms in a more systematic way by targeting specific regulatory regions relevant for the phenotype studied. We applied this method to meningococcal disease susceptibility, using the DNA binding pattern of RELA - a NF-kB subunit, master regulator of the response to infection - under bacterial stimuli in nasopharyngeal epithelial cells. We designed a custom panel to cover these RELA binding sites and used it for targeted sequencing in cases and controls. Variant calling and association analysis were performed followed by validation of candidate polymorphisms by genotyping in three independent cohorts. We identified two new polymorphisms, rs4823231 and rs11913168, showing signs of association with meningococcal disease susceptibility. In addition, using our genomic data as well as publicly available resources, we found evidences for these SNPs to have potential regulatory effects on ATXN10 and LIF genes respectively. The variants and related candidate genes are relevant for infectious diseases and may have important contribution for meningococcal disease pathology. Finally, we described a novel genetic association approach that could be applied to other phenotypes.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideRegulatory Sequences, Nucleic AcidCase-Control StudiesCohort StudiesGenetic Association StudiesGenomicsHigh-Throughput Nucleotide SequencingHumansHypopharyngeal NeoplasmsMeningococcal InfectionsNeisseria meningitidisPhenotypeTumor Cells, Cultured

Identifiers

PMID31061469
PMCPMC6502852
OpenAlexW2943368871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.